COLRF (Tian An Medicare) ROE %: -4.34% (As of Dec. 2025)


COLRF Tian An Medicare Ltd COLRF
36 GF Score
Price $0.08
GF Value $0.07
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare ROE %?

Tian An Medicare COLRF 36 ROE % is -4.34% as of Dec. 2025. GuruFocus rates COLRF with a GF Score™ of 36/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 70.7% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Tian An Medicare's annualized net income for the quarter that ended in Dec. 2025 was $-10.0 Mil. Tian An Medicare's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was $229.8 Mil. Therefore, Tian An Medicare's annualized ROE % for the quarter that ended in Dec. 2025 was -4.34%.

The historical rank and industry rank for Tian An Medicare's ROE % or its related term are showing as below:

COLRF' s ROE % Range Over the Past 10 Years
Min: -42.94   Med: -4.93   Max: 1.93
Current: -1.49

During the past 13 years, Tian An Medicare's highest ROE % was 1.93%. The lowest was -42.94%. And the median was -4.93%.

COLRF's ROE % is ranked worse than
70.7% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs COLRF: -1.49

Tian An Medicare  (OTCPK:COLRF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-9.972/229.8015
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-9.972 / 219.784)*(219.784 / 447.1365)*(447.1365 / 229.8015)
=Net Margin %*Asset Turnover*Equity Multiplier
=-4.54 %*0.4915*1.9458
=ROA %*Equity Multiplier
=-2.23 %*1.9458
=-4.34 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-9.972/229.8015
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-9.972 / -6.19) * (-6.19 / 3.596) * (3.596 / 219.784) * (219.784 / 447.1365) * (447.1365 / 229.8015)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.611 * -1.7214 * 1.64 % * 0.4915 * 1.9458
=-4.34 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Tian An Medicare ROE % Related Terms


Tian An Medicare ROE % Historical Data

* Premium members only.

The historical data trend for Tian An Medicare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tian An Medicare ROE % Chart

Tian An Medicare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.85 -7.75 0.89 1.59 -1.49

Tian An Medicare Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 2.39 0.78 1.31 -4.34

COLRF vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Tian An Medicare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tian An Medicare ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's ROE % distribution charts can be found below:

* The bar in red indicates where Tian An Medicare's ROE % falls into.


COLRF
36GF Score
Tian An Medicare Ltd COLRF
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tian An Medicare ROE % Calculation

Tian An Medicare's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-3.446/( (234+227.914)/ 2 )
=-3.446/230.957
=-1.49 %

Tian An Medicare's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-9.972/( (231.689+227.914)/ 2 )
=-9.972/229.8015
=-4.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -4.34% mean?
Tian An Medicare (COLRF) has a ROE % of -4.34% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tian An Medicare and its competitors. According to the industry distribution chart, Tian An Medicare ranks #444 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 70.7%.
Is Tian An Medicare's ROE % too high?
Tian An Medicare's current ROE % is -4.34%. Based on the distribution chart, Tian An Medicare ranks #444 out of 628 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tian An Medicare has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #444 out of 628 companies for ROE %. This places Tian An Medicare in the lower half of its industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tian An Medicare and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current ROE % is -4.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current ROE % of -4.34%. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current ROE % is -4.34%. Tian An Medicare's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current ROE % is -4.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tian An Medicare (COLRF) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.

Key valuation signals for COLRF:

  • ROE %: -4.34%
  • GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tian An Medicare Business Description

Other Exchanges 00383:Hong KongSMI:Germany
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
36GF Score

Get the complete analysis for COLRF

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.07
GF Value